Primary record
(7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentyldihydrosulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- 库存
- 9,202 克
- 纯度
- 99.3 %
- CAS
- 129453-61-8
化合物标识与属性
- CAS
- 129453-61-8
- PubChem CID
- 104741
- SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
- Canonical SMILES
- C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
名称与同义词
- Fulvestrant
- Faslodex
- 129453-61-8
- fulvestrantum
- Fluvestrant
- Falsodex
- Fulvestrant [USAN]
- Fulvestrant?
- Ici 182780
- Fulvestrant CRS
- Faslodex (TN)
- ICI 182,780
- ICI-182780
- Fulvestrant S enantiomer
- Fulvestrant (Faslodex)
- Fulvestrant (Standard)
- Fulvestrant R enantiomer
- C32H47F5O3S
- RefChem:57293
- DTXSID4022369
- AC1L2XEN
- FULVESTRANT [MI]
- ZD-9238
- CHEMBL1358
- Faslodex(ICI 182,780)
- FULVESTRANT [INN]
- FULVESTRANT [JAN]
- ZD9238
- D0JO7Y
- FULVESTRANT [VANDF]
- UNII-22X328QOC4
- SCHEMBL8209
- ZM-182780
- CCRIS 8741
- DTXCID202369
- VWUXBMIQPBEWFH-WCCTWKNTSA-N
- 22X328QOC4
- FULVESTRANT [MART.]
- BIDD:PXR0136
- ICI182780
- FULVESTRANT [USP-RS]
- FULVESTRANT [WHO-DD]
- CHEBI:31638
- HSDB 7658
- MLS006010187
- BIDD:ER0348
- Fulvestrant (JAN/USP/INN)
- Fulvestrant (JAN/USAN/INN)
- FULVESTRANT [EMA EPAR]
- Fulvestrant, >98% (HPLC)
- GTPL1015
- orb1306347
- ZM 182780
- AstraZeneca brand of fulvestrant
- Fulvestrant - Bio-X trade mark
- Fulvestrant [USAN:USP:INN:BAN]
- NSC-759879
- SCHEMBL29353866
- CTK8F0501
- EX-A959
- FULVESTRANT [ORANGE BOOK]
- ICI 182,780 (Fulvestrant)
- L02BA03
- MSK8055
- ZD 182780
- MFCD00903953
- NSC719276
- FULVESTRANT [EP MONOGRAPH]
- FULVESTRANT [USP IMPURITY]
- Fulvestrant CRS (Y0001399)
- GLXC-03001
- HMS2090N22
- HMS3260G10
- HMS3712A06
- FULVESTRANT [USP MONOGRAPH]
- Tox21_110939
- Tox21_202604
- Tox21_303656
- Tox21_500114
- ZD-182780
- ABP001070
- BDBM50169743
- C32-H47-F5-O3-S
- CID104741
- EBC-11252
- HB2501
- HY-13636R
- MSK8055-100M
- ZM182780
- AKOS015895669
- Faslodex, ICI 182780, Fulvestrant
- Fulvestrant for system suitability CRS
- Tox21_110939_1
- AC-4693
- ACN-029814
- AN-5482
- BCP9000707
- CCG-220082
- CCG-221418
- CID:104741
- CS-1267
- DB00947
- FF23615
- ICI182,780
- ICI182/780
- LP00114
- NSC 759879
- NSC-719276
- SDCCGSBI-0633685.P001
- ICI 182 780
- ICI 182.780
- ICI-182,780
- NCGC00024964-02
- NCGC00164789-02
- NCGC00164789-04
- NCGC00257357-01
- NCGC00260152-01
- NCGC00260799-01
- NCGC00386134-10
- AS-13024
- BC678123
- BI167222
- DA-63628
- H046
- HY-13636
- LS-64781
- SC-19202
- SMR001456109
- BCP0726000227
- SID:376229567
- (7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
- AB0012854
- J401.163E
- RT-013311
- A1428
- CAS-129453-61-8
- CS-0694849
- F1144
- Fulvestrant Solution in Methanol, 100ug/mL
- NS00004276
- S1191
- Estra-1,3,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-, (7alpha,17beta)-
- Fulvestrant, Vetec(TM) reagent grade, >98%
- D01161
- EN300-120628
- W-5207
- AB01273957-01
- AB01273957-02
- AB01273957-03
- AB01273957_04
- 453F618
- 7alpha-(9-((4,4,5,5,5-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol
- C070081
- (7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- A1200246
- I06-1109
- Q5508491
- BRD-A85667082-001-12-7
- Fulvestrant for System Suitability CRS (Y0001413)
- D000077267
- 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol
- Fulvestrant, European Pharmacopoeia (EP) Reference Standard
- (7R,13S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- 1316849-17-8
- Estra-1,3,5(10)-triene-3,17-diol, 7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-, (7alpha,17beta)-
- Fulvestrant, United States Pharmacopeia (USP) Reference Standard
- (1S,3aS,3bR,4R,9bS,11aS)-11a-methyl-4-[9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl]-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1,7-diol
- (7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17-diol
- (7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol
- (7R,8S,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl) nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
- 1807900-80-6
- 7alpha-(9-((4,4,5,5,5,-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol
- Fulvestrant for system suitability, European Pharmacopoeia (EP) Reference Standard
- (13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- (1S,3aS,3bR,4R,9bS,11aS)-11a-methyl-4-(9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl)-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta(a)phenanthrene-1,7-diol
- (1S,9R,10R,11S,14S,15S)-15-methyl-9-[9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,14-diol
- (1S,9R,10R,11S,14S,15S)-15-methyl-9-[9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-triene-5,14-diol
- (1S,9R,11S,14S,15S)-15-methyl-9-(9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl)tetracyclo(8.7.0.02,7.011,15)heptadeca-2,4,6-triene-5,14-diol
- (7-alpha,17-beta)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol
- (7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol
- (7a,17b)-7-[9-[4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol
- (7alpha,17beta)-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)estra-1(10),2,4-triene-3,17-diol
- (7R,13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- (7R,17S)-7-[9-[(4,4,5,5,5-Pentafluoropentylsulfinyl)]nonyl]estra-1(10),2,4-triene-3,17-diol
- (7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentyldihydrosulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- (7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta(a)phenanthrene-3,17-diol
- (7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- (7R,8R,9S,13S,14S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- (7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfanyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
- (7R,9S,13S,14S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
- 13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- 13-Methyl-7-[9-(4,5,5,5-pentafluoropentylsulfinyl)nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- 153004-31-0
- 642-998-6
- 7.ALPHA.-(9-(4,4,5,5,5-PENTAFLUOROPENTYLSULPHINYL)NONYL)ESTRA-1,3,5(10)-TRIENE-3,17.BETA.-DIOL
- 7a-(9-((4,4,5,5,5,-Pentafluoropentyl)sulphinyl)nonyl)-estra-1,3,5(10)-triene-3,17b-diol
- 7alpha-[9-(4,4,5,5,5-pentafluoro-pentylsulfinyl)nonyl]estra-1,3,5(10)-triene-3,17beta-diol
- 7alpha-[9-(4,4,5,5,5-Pentafluoropentane-1-sulfinyl)nonyl]estra-1,3,5(10)-triene-3,17beta-diol
- 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]estra-1,3,5(10)-triene-3,17beta-diol
- 7alpha-[9-[(4,4,5,5,5-Pentafluoropentylsulfinyl)]nonyl]estra-1(10),2,4-triene-3,17beta-diol
- 7alpha-[9[(4,4,5,5,5-Pentafluropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3, 17 beta diol
- 7alpha-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17beta-diol
- ESTRA-1,3,5(10)-TRIENE-3,17-DIOL, 7-(9-((4,4,5,5,5-PENTAFLUOROPENTYL)SULFINYL)NONYL)-, (7.ALPHA.,17.BETA.)-
- Estra-1,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-, (7.alpha.,17.beta.)-
- Faslodex; Fulvestrant; ICI 182780; ZD 182780; ZD 9238; ZM 182780; 7alpha-[9-[(RS)-(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17beta-diol
- ICI